... gene p53 that is commonly mutated in human prostate cancers. Hence the researchers hypothesized that tumors ... alleles with transgenic mice that develop spontaneous prostate cancer when p53 and select other genes are compromised ...
... Institute for Medical Research have shown that there is a link between prostate cancer and a higher risk of bone fracture ... .” “The clear message that comes out of this study is that men with prostate cancer should consider seeking evaluation ...
... choice to make,” Aronson said. “Whether or not it will prevent prostate cancer in humans remains to be seen.” Aronson ... tissue known to be important for development and progression of prostate cancer,” he said. “It’s this work we hope will lead ...
... -beam radiation therapy (EBRT) for localized prostate cancer may be at an increased risk for secondary malignancy ... for men evaluating treatment options for localized prostate cancer. Using records from 10,333 men ...
Patients undergoing external-beam radiation therapy for localized prostate cancer may be at an increased risk for secondary malignancy, according to a new study.
... African-American men with a family history of prostate cancer. The volunteers were divided into three groups ... and a baseline PSA below the median were diagnosed with prostate cancer. Eight percent of men in their 40s ...
... apex for radiation therapy treatment planning in prostate cancer patients because it eliminates the need ... contrast, is the standard method used to identify the area of the prostate to be treated with radiation. However, this method is invasive ...
... (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity ... that challenge, he said. HIFU is becoming more common as a prostate cancer treatment option, particularly for those persons ...
... in the treated animals. “Adenomas are not commonly found to be part of prostate-cancer development in this system,” he says. “This drug ... strain of the same mouse – they do not develop prostate cancer – showed that the degeneration of the testicles that accompanied ...
... experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease ... ) inhibitors, compounds designed to reactivate genes that normally protect against cancer but are turned off ...
... says. Answering that question required the analysis of 455 prostate cancer samples from trials in Sweden and the United ... role in regulating (and encouraging) this aggressive subset of prostate cancer. While estrogen is typically thought ...
... years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that fuels prostate-cancer growth - via surgical castration (orchiectomy ...
... the body's own immune system to fight prostate cancer. The drug was found to be effective in study participants ... we have seen, this shows that the immune system can be useful to treat prostate cancer. Results show that in some patients, the immune ...
... , blood and tissue that can be a signal of a disease – for a subtype of prostate cancer. The findings, reported in the June issue ... , such as leukemias and lymphomas, but not in common solid tumors such as prostate cancer. Chinnaiyan's discovery demonstrated that these gene ...
... cases. Using this methodology to examine data from seven prostate cancer profiling studies, they identified SPINK1 ... expression was shown to be an effective independent predictor of prostate cancer recurrence after surgical resection. Further ...
